Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Tyrosine Protein Kise Fyn (Proto Oncogene Syn or Proto Oncogene c Fyn or Src Like Kise or p59 Fyn or FYN or EC 2.7.10.2) - Overview
Tyrosine Protein Kise Fyn (Proto Oncogene Syn or Proto Oncogene c Fyn or Src Like Kise or p59 Fyn or FYN or EC 2.7.10.2) - Therapeutics Development
Products under Development by Stage of Development
Products under Development by Therapy Area
Products under Development by Indication
Products under Development by Companies
Products under Development by Universities/Institutes
Tyrosine Protein Kise Fyn (Proto Oncogene Syn or Proto Oncogene c Fyn or Src Like Kise or p59 Fyn or FYN or EC 2.7.10.2) - Therapeutics Assessment
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Tyrosine Protein Kise Fyn (Proto Oncogene Syn or Proto Oncogene c Fyn or Src Like Kise or p59 Fyn or FYN or EC 2.7.10.2) - Companies Involved in Therapeutics Development
AB Science SA
AstraZeneca Plc
Bristol-Myers Squibb Co
MAA Laboratories Inc
PK Biosciences Corp
ValiRx Plc
Zen-Bio Inc
Tyrosine Protein Kise Fyn (Proto Oncogene Syn or Proto Oncogene c Fyn or Src Like Kise or p59 Fyn or FYN or EC 2.7.10.2) - Drug Profiles
CP-14028 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CP-15078 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Tyrosine Protein Kise Fyn (Proto Oncogene Syn or Proto Oncogene c Fyn or Src Like Kise or p59 Fyn or FYN or EC 2.7.10.2) - Dormant Products
Tyrosine Protein Kise Fyn (Proto Oncogene Syn or Proto Oncogene c Fyn or Src Like Kise or p59 Fyn or FYN or EC 2.7.10.2) - Discontinued Products
Tyrosine Protein Kise Fyn (Proto Oncogene Syn or Proto Oncogene c Fyn or Src Like Kise or p59 Fyn or FYN or EC 2.7.10.2) - Product Development Milestones
Featured News & Press Releases
Appendix



List of Figures


Number of Products under Development by Stage of Development, H1 2020
Number of Products under Development by Therapy Areas, H1 2020
Number of Products under Development by Top 10 Indications, H1 2020
Number of Products by Stage and Mechanism of Actions, H1 2020
Number of Products by Routes of Administration, H1 2020
Number of Products by Stage and Routes of Administration, H1 2020
Number of Products by Molecule Types, H1 2020
Number of Products by Stage and Molecule Types, H1 2020


List of Tables


Number of Products under Development by Stage of Development, H1 2020
Number of Products under Development by Therapy Areas, H1 2020
Number of Products under Development by Indications, H1 2020
Number of Products under Development by Indications, H1 2020 (Contd..1), H1 2020
Number of Products under Development by Indications, H1 2020 (Contd..2), H1 2020
Number of Products under Development by Companies, H1 2020
Products under Development by Companies, H1 2020
Products under Development by Companies, H1 2020 (Contd..1), H1 2020
Products under Development by Companies, H1 2020 (Contd..2), H1 2020
Products under Development by Companies, H1 2020 (Contd..3), H1 2020
Number of Products under Investigation by Universities/Institutes, H1 2020
Products under Investigation by Universities/Institutes, H1 2020
Number of Products by Stage and Mechanism of Actions, H1 2020
Number of Products by Stage and Route of Administration, H1 2020
Number of Products by Stage and Molecule Type, H1 2020
Pipeline by AB Science SA, H1 2020
Pipeline by AstraZeneca Plc, H1 2020
Pipeline by Bristol-Myers Squibb Co, H1 2020
Pipeline by MAA Laboratories Inc, H1 2020
Pipeline by PK Biosciences Corp, H1 2020
Pipeline by ValiRx Plc, H1 2020
Pipeline by Zen-Bio Inc, H1 2020
Dormant Products, H1 2020
Dormant Products, H1 2020 (Contd..1), H1 2020
Dormant Products, H1 2020 (Contd..2), H1 2020
Discontinued Products, H1 2020